Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 851 - 900 out of 12,881

Document Document Title
WO/2009/096352A1
Disclosed is an arylsulfonic acid compound characterized by being represented by formula (1). By using this compound as an electron-acceptor material, highly uniform film formability can be achieved. By using a thin film containing the a...  
WO/2009/096993A1
The present invention relates to a formulation comprising a N-halogenated amino acid and a phase transfer agent. The present invention also describes a method for disinfecting and/or cleaning a contact lens comprising contacting a contac...  
WO/2009/095324A1
The present invention provides novel compounds of the general formula (I), and pharmaceutically acceptable salts thereof, processes for the manufacture of these novel compounds and medicaments, containing them. The compounds of the prese...  
WO/2009/072144A3
The invention relates to a monomelic antimicrobial agent, to a copolymer and polymer compositions having antimicrobial activity and to articles and products prepared from them. The invention also relate to methods for preparing the anti ...  
WO/2009/091702A1
Fluorine-free photoacid generators and photoresist compositions containing fluorine-free photoacid generators are enabled as alternatives to PFOS/PFAS photoacid generator-containing photoresists. The photoacid generators are characterize...  
WO/2009/091040A1
Disclosed is a method for producing a spilanthol on a large scale without using any expensive reagent. Specifically disclosed is a method for producing N-isobutyl-2,6,8-decatrienamide, which is characterized in that no purification proce...  
WO/2009/085964A1
A process for preparing a synthetic petroleum sulfonate comprising (a) reacting a first amount of at least one aromatic compound with a first amount of a mixture of olefins having from about 8 to about 100 carbon atoms, in the presence o...  
WO/2009/082346A1
The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), or an enantiomer thereof, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, E, L, Z and n are as defined her...  
WO/2009/081956A1
Disclosed is a method for producing a conjugated aromatic compound, which is characterized in that an aromatic compound (A) having one or two leaving groups bonded to an aromatic ring is reacted with another aromatic compound (A) having ...  
WO/2009/080365A1
Pharmaceutically acceptable acid addition salts of pregabalin that are isolatable in solid state, particularly crystalline state, sufficiently soluble in water, and stable both in the solid state and in the solution, as well as methods o...  
WO/2009/052970A3
This invention relates to novel compounds suitable for labelling or already labelled by 18F, methods of preparing such a compound, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such co...  
WO/2009/078335A1
Disclosed is a sulfonate represented by the general formula (1) below. (In the formula, Rf's independently represent a fluorine atom or a perfluoroalkyl group having 1-3 carbon atoms; R1 represents a linear or branched alkyl group having...  
WO/2007/035718A3
The present invention relates to crystalline polymorphic forms of the di- sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, pharmaceutical compositions containing the same, methods of preparing the same, and methods for facilit...  
WO/2009/073427A1
The invention provides novel aryl and aliphatic esters of fluorinated alkanesulfonic acids. The invention also provides novel fluorinated alkanesulfonamides and a process to make the same. The invention also provides a process for the ar...  
WO/2009/072480A1
A process for producing 2-acdrylamide-2-methylpropanesulfonic acid (ATBS) which comprises reacting acrylonitrile, fuming sulfuric acid, and isobutylene. During the reaction, the concentration of 2-methyl-2-propenyl-1-sulfonic acid (IBSA)...  
WO/2009/072144A2
The invention relates to a monomelic antimicrobial agent, to a copolymer and polymer compositions having antimicrobial activity and to articles and products prepared from them. The invention also relate to methods for preparing the anti ...  
WO/2009/073426A2
The invention provides a process for the preparation of fluorinated alkanesulfonic acid anhydrides by contacting alkanesulfonic acids with phosphorus pentoxide, the phosphorus pentoxide being provided as a dispersion in an inert oil. The...  
WO/2008/142482A3
The present invention relates to compositions comprising at least omega-3 lipid compounds substituted at the 2-positions having therapeutic activity. More specifically, the present invention relates to a composition comprising at least o...  
WO/2009/068509A1
This invention relates to novel benzamide derivatives that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive ...  
WO/2009/069311A1
Disclosed is a simple method for efficiently producing a 3-mercaptoaniline compound which is known as an intermediate for a 3-(1H-1,2,4-triazol-1-yl)phenylsulfide derivative that is useful as a pesticide and the like. Also disclosed is a...  
WO/2009/020906A3
A surfactant of formula (1) A surfactant of formula 1 (Rf-A)a- Q- ([B]k-R)b Formula 1 wherein a and b are each independently 1 or 2; Rf is a linear or branched perfluoroalkyl radical having from 2 to about 20 carbon atoms, optionally int...  
WO/2007/095584A3
In recognition of the need to develop novel therapeutic agents, the present invention provides novel histone deacetylase inhibitors. These compounds include an ester bond making them sensitive to deactivation by esterases. Therefore, the...  
WO/2008/009815A3
The invention relates to aromatic sulfonates, the preparation thereof, and the use of the same as the salt of an electrolyte. The sulfonates have the formula [Ar-Z- (CF2)nCFRf-SO3 -] p Mp+ (I), wherein Z is a sulfide, sulfinyl or sulfony...  
WO/2009/060815A1
A process for the preparation of trifluoromethanesulfonyl fluoride (CF3SO2F) by reacting trifluoromethanesulfonyl chloride (SF3SO2Cl) with a metal fluoride in the presence of water, characterized in that the amount of water is 0.6 to 10....  
WO/2009/057769A1
Disclosed is a fluorinated sulfonic acid salt having the structure represented by the general formula (A) or a compound having a fluorinated sulfonate group. (A) wherein n represents an integer of 1 to 10; R represents a substituted or u...  
WO/2009/057515A1
Disclosed are (1) a novel phenyl sulfonate compound, (2) a nonaqueous electrolyte solution obtained by dissolving an electrolyte in a nonaqueous solvent, wherein a phenyl sulfonate compound represented by the general formula (II) below i...  
WO/2009/052970A2
This invention relates to novel compounds suitable for labelling or already labelled by 18F, methods of preparing such a compound, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such co...  
WO/2006/014405A3
Various sulfonamide-based compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteopor...  
WO/2009/054406A1
(1) A solid fatty acid alkyl ester sulfonate metal salt material characterized by having an endothermic peak area at 50 to 130°C of 50% or more relative to the whole endothermic peak area at 0 to 130°C as measured on a differential sca...  
WO/2009/054240A1
Hexamethylphosphoramide (HMPA) is added to a reaction vessel containing (R)-1,1'-binaphthyl-2,2'-dithiol and potassium hydroxide. The reaction vessel is purged with oxygen, and is stirred at 80°C for 5 days under 7 atmospheres of oxygen...  
WO/2009/051666A1
Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid) and anandamide (an endogenous ligand for cannabinoid receptors). Disclosed herein are potent inhibitors of FA...  
WO/2009/050179A1
Surfactants with a polyethersulfonate structure having a propanoylsulphonic acid as head group, method for production of such surfactants and use thereof for tertiary crude oil production.  
WO/2009/051088A1
Disclosed is a compound having a partial structure represented by the general formula (1) below. (In the formula (1) below, R1's independently represent a hydrogen atom or a hydrocarbon group; R2 represents a hydrocarbon group; Rf repres...  
WO/2003/082205A3
Disclosed is a compound having the formula (I) pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and so...  
WO/2009/037981A1
By using an organic base when a carboxylic acid bromodifluoroethyl ester is sulfinated by using a sulfinating agent, there is obtained 2-(alkylcarbonyloxy)-1,1-difluoroethanesulfinic acid ammonium salt. By oxidizing the 2-(alkylcarbonylo...  
WO/2009/037980A1
Disclosed is a process for producing 2-bromo-2,2- difluoroethanol, which comprises reducing a bromodifluoroacetic acid derivative represented by the formula [1] by using an ate hydride complex as a reducing agent. 2-Bromo-2,2-difluoroeth...  
WO/2009/033054A1
Pantoic acid ester neopentyl sulfonyl ester prodrugs of acamprosate of formula (I), pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In...  
WO/2009/033069A1
Pantoic acid ester neopentyl sulfonyl ester prodrugs of acamprosate of formula (I), pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In...  
WO/2009/033061A1
Masked carboxylate neopentyl sulfonyl ester prodrugs of acamprosate of formula (I), pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In...  
WO/2009/033079A1
Masked nitrogen-substituted and oxygen-substituted neopentyl sulfonyl ester prodrugs of acamprosate of formulae (I) and (III), pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions ther...  
WO/2009/027108A1
The present invention relates to a new process for preparing estrogen-antagonistic 11 β-fluoro-17α-alkylestra-1,3,5(10)-triene-3,17-diols of the general formula (I) having a 7α-(ξ-alkylamino-ω-perfluoroalkyl)alkyl side chain and to ...  
WO/2009/029633A1
The invention relates to new processes for preparation of 18F-labelled alkylation reagents that can be used in the alkylation of amines that are suitable for use in labelling of Positron Emission Tomography (PET) radiotracers. (I)  
WO/2008/152334A3
The invention relates to novel derivatives of 3-phenyl acrylic acid of the following general formula (I), to a method for preparing the same, and to the use thereof in pharmaceutical compositions used in human or veterinary medicine (in ...  
WO/2009/025391A1
Disclosed is a method for producing a dihalobiphenyl compound, which is characterized by comprising a process wherein an aqueous solution containing an inorganic salt and a dihalobiphenyl compound represented by the formula (1) below is ...  
WO/2009/022681A1
Disclosed is a positive resist composition which is good in pattern shape, line-edge roughness, pattern collapse, sensitivity and resolution in conventional exposure (dry exposure), liquid immersion exposure and double exposure. Also dis...  
WO/2008/152333A3
The invention relates to novel derivatives of 3-phenyl propanoic acid of the following general formula (I), to a method for preparing the same, and to the use thereof in pharmaceutical compositions used in human or veterinary medicine (i...  
WO/2008/139121A3
The invention relates to a method for the synthesis of (Z)-3-[2-butoxy-3'-(3-heptyl-1 - methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid having formula (I) and to the method for the synthesis of the reaction intermediates having gene...  
WO/2009/019534A2
The invention relates to methods, compounds, compositions and vehicles for delivering 3-amino-1 -propanesulfonic acid (3APS) in a subject, preferably a human subject. The invention encompasses compounds that will yield or generate 3APS, ...  
WO/2009/020906A2
A surfactant of formula (1) A surfactant of formula 1 (Rf-A)a- Q- ([B]k-R)b Formula 1 wherein a and b are each independently 1 or 2; Rf is a linear or branched perfluoroalkyl radical having from 2 to about 20 carbon atoms, optionally int...  
WO/2009/020908A1
A compound comprising Formula I, or a mixture thereof, wherein Y is a bond or CmH2m-p(OA)p wherein m is 0 to 4, and p is 0 or 1, X' is X or H, X is CH2CH2OA, CH(CH2OA)2, C(CH2OA)3, or X and X' combine to form (CH2H2)2NCH2CH2OA or (CH2CH2...  

Matches 851 - 900 out of 12,881